How Hospital Management Software Can Enhance Your Bottom Line

Hospital management software can help hospitals enhance patient outcomes while boosting operational efficiencies. VigiLanz’ award-winning platform accomplishes both goals through clinical surveillance, safety, quality, and risk solutions. However, the benefits don’t end there – our hospital management software can also have a positive impact on margins.

An economic value assessment of our platform shows that hospitals can save millions by using VigiLanz. To see how much an individual hospital can save, we created an economic value calculator that provides a customized analysis with only a few data points – annual inpatient admissions, number of staffed beds, and daily census.

The calculator breaks out the positive economic impact of a hospital management system into three key areas:

  • Cost savings: This includes faster, more proactive identification of opportunities to cut costs, such as IV to PO conversions, and more optimal management of high-cost drugs.
  • Cost avoidance: This includes the reduction of costly events such as hospital-acquired infections or conditions, acute kidney injuries due to antibiotic use, and adverse drug events, readmissions, and return visits to the emergency department.
  • Returned resources: This includes the value of time saved by transitioning from manual to automated workflows.

Reducing financial strain is especially important as hospitals continue to see skyrocketing expenses and declining revenues. A hospital management system offers a path toward improved margins, while also producing greater efficiencies and improved patient outcomes.

Want to learn more about the many benefits of hospital management software and how much you might save by working with VigiLanz? Check out these additional resources:

How Hospitals are Using Clinical Surveillance Platforms to Improve Patient Safety

Clinical intelligence provided by clinical surveillance platforms is an essential tool in hospitals’ toolboxes to improve patient outcomes, staff satisfaction, and workflow efficiency. But don’t take it from us – hospitals around the country are seeing the benefits of implementing our clinical surveillance platform across their patient safety initiatives.

Our latest Vigi Award winners, a group of nine individuals and teams recognized for using clinical intelligence from VigiLanz in creative ways to improve patient safety, is a testament to the power of clinical surveillance platforms. Read on to hear more about some of the creative uses:

Pharmacy Surveillance:

1. Quickly identifying patients in need of new medications or eligible for medication discontinuation using VigiLanz alerts – Freeman Health Pharmacy Team

2. Contributing to the quick identification of patients most in need of a comprehensive medical review through custom VigiLanz rules and reports – Benefits Health System Pharmacy Team

3. Using VigiLanz rule-based alerts to help appropriately decrease use of antibiotics for patients with MRSA pneumonia – Houston Methodist The Woodlands Hospital Pharmacy and Antimicrobial Stewardship Team

4. Identifying pediatric patients using VigiLanz who may no longer be allergic to Penicillin and could benefit from it – Cincinnati Children’s Hospital Medical Center Stewardship Team

Infection Prevention:

1. Being an outstanding leader in the field of infection prevention and spearheading multiple product improvements, alerts, customized reports and activations – Adriana Jimenez, PhD, Infection Prevention Manager at Jackson Health System

2. Expertly putting clinical surveillance ideas into action to help her teams maximize their use of VigiLanz – Dechen Lama, IT Systems Administrator, Mount Sinai Health System

3. Creating novel dashboards and worksheets using VigiLanz to inform HAI prevention efforts – Laura Stines, Infection Prevention Data Analyst, Cone Health System

Safety Surveillance:

1. Enhancing error reporting processes and improving quality of reports using VigiLanz medication error reporting tools. – CHRISTUS Health Safety Team

2. Detecting instances of drug diversions and conducting data-driven investigations to monitor care using data provided by VigiLanz – HCA Healthcare Continental Division

Want to learn more about how VigiLanz’ clinical surveillance platform can provide clinical intelligence and support your hospital? Contact us today to learn more.

Freeman Health System Pharmacy Uses VigiLanz to Improve Care, Workflows, and Costs


freeman health system logo

Freeman Health System, a 485-bed, three-hospital system in Joplin, Missouri, serves a population of 450,000 people across Missouri, Arkansas, Kansas, and Oklahoma. Ranked one of the top hospitals in Missouri by U.S. News & World Report, Freeman continually seeks out new and innovative ways to improve patient care.

Within Freeman, the pharmacy department is known for its commitment to exploring new tools that improve efficiency as well as patient safety. Since implementing VigiLanz in 2018, Freeman’s pharmacy team has created over 650 VigiLanz rules that aid in pharmacy department interventions. These rules use dashboards and real-time notifications to alert team members whenever information pulled from the electronic health record (EHR) meets rule criteria. 

“This approach has made a significant impact on patient care, pharmacy workflows, and costs,” said Adrienne Carey, PharmD, BCPS, Clinical Pharmacist and Data Mining Program Manager at Freeman Health System. “Because of the improved capabilities within VigiLanz’s rule engine, we’ve been able to identify more opportunities for intervention more quickly than before.”

Here are five examples of how the Freeman team used VigiLanz’s pharmacy workflow solutions to support key initiatives that improved patient care and safety while reducing costs.

Initiative #1: Rule-building to inform discharge counseling

Each year, Freeman Health System residents use VigiLanz to build rules or create data mining searches to identify patient populations and gather data for a 12-month research project. This year, residents used VigiLanz rules to identify cardiology patients who were being discharged with a new medication not listed on their home medication list.

When the rule was triggered, pharmacists received a real-time alert. Pharmacists then educated patients about their new medication(s), documented them in the activation, and followed up with patients to assess the effectiveness of the education and its impact on readmission rates. Since these cardiology patients typically had a short length of stay, the VigiLanz rules were especially helpful in quickly identifying appropriate patients for education.

The patients who received education from pharmacy were 11% more likely to remember their counseling than those who received education through other discharge processes. Patients with the pharmacy education also had a 30-day readmission rate of 5.25% (compared to a rate of 21.25% among those who did not receive the education).

Initiative #2: Validation studies to support antibiotic discontinuation

A negative Methicillin-resistant Staphylococcus aureus (MRSA) nasal screening can help providers determine when to safely discontinue vancomycin, an antibiotic commonly used in patients with MRSA. However, since some providers are reluctant to discontinue the drug based on this test, another Freeman resident used VigiLanz to quantify the probability of disease based on screening results.

The resident created VigiLanz data mining searches to capture MRSA+ screens with positive cultures, MRSA+ screens with negative cultures, MRSA- screens with positive cultures, and MRSA- screens with negative cultures. Results showed a 97.2% correlation that a negative MRSA screen resulted in no MRSA infection. This enhanced providers’ confidence in using the screen to safely discontinue vancomycin, and therefore, reduced the risk of antimicrobial resistance and adverse events.

Initiative #3: Alerts to decolonize patients with positive MRSA screens

Studies indicate that MRSA colonization in the nose could increase the risk of MRSA infection, and that nasal administration of Mupirocin ointment reduces infections in patients with positive MRSA nasal screens. Based on this information, Freeman created a new protocol that authorized pharmacists to order Mupirocin ointment nasally when a patient has a positive MRSA nasal screen.

Freeman then used VigiLanz rules to identify patients with positive MRSA screens and alert pharmacists in real time. Since implementing this rule in January 2022, the facility has ordered Mupirocin decolonization for 162 patients, resulting in $98,000 in estimated cost savings due to less time spent in isolation, lowered risk of infection, and fewer readmissions.

Initiative #4: Tools to monitor drugs and prevent drug shortages 

Freeman’s pharmacy team uses VigiLanz to quickly and efficiently search for pharmacy orders (a functionality not included in their health information system). Examples include:

  • Central staff and buyers use VigiLanz to identify patients on medications in short supply so that pharmacists can alert providers and help prevent drug shortages.
  • Pharmacists use VigiLanz to search for high alert drugs to monitor proactively. Floor pharmacists run a system-wide kinetics search each morning—including vancomycin, heparin, and aminoglycosides—to identify the patients they are expected to manage.
  • Night shift pharmacists use pharmacy orders to identify heparin patients that need to be monitored.

Initiative #5: Rules to guide and decrease antibiotic use

A Freeman pharmacy resident used VigiLanz to conduct a research project comparing Freeman providers’ antibiotic orders (including Zithromax, Aztreonam, Cefepime, Ceftriaxone, Ciprofloxacin, Levofloxacin, Meropenem, Zosyn, and vancomycin) for treating pneumonia according to professional guidelines. The study found that, for each type of pneumonia, some antibiotics were prescribed for longer than recommended. As a result, Freeman created order sets to guide providers about the appropriate number of days to prescribe each antibiotic.

Freeman also created a “Pneumonia Pathway Hard Stop” rule in VigiLanz to ensure the hard stop stays with the antibiotic order, regardless of any dosage changes made that could inadvertently remove the initial hard stop.

As a result, floor pharmacists can more easily determine when patients complete their therapies, and Freeman can reduce its usage of antibiotics consistent with professional guidelines.


To learn more about how VigiLanz helps hospitals improve their patient safety and clinical surveillance, visit today.